Skip to content
10-Q

Quarterly Report

MEDMEN ENTERPRISES INC.

0001829126-22-018581

← back to feed
Filed
Nov 3, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Oct 31, 2022 1.3B sh
Operating Cash Flow Q1 2023 · Sep 24, 2022 −$9.61M
Operating Cash Flow restated Q1 2023 · Sep 25, 2021 −$22.98M
Cash And Equivalents Q1 2023 · Sep 24, 2022 $21.1M
Cash And Equivalents Q1 2023 · Jun 25, 2022 $10.8M
Stockholders Equity Q1 2023 · Sep 24, 2022 $160.53M
Stockholders Equity Q1 2023 · Jun 25, 2022 $155.47M
Current Liabilities Q1 2023 · Sep 24, 2022 $233.58M
Current Liabilities Q1 2023 · Jun 25, 2022 $319.59M
Total Liabilities Q1 2023 · Sep 24, 2022 $564.7M
Total Liabilities Q1 2023 · Jun 25, 2022 $641.74M
Current Assets Q1 2023 · Sep 24, 2022 $98.68M
Current Assets Q1 2023 · Jun 25, 2022 $161.5M
Total Assets Q1 2023 · Sep 24, 2022 $251.13M
Total Assets Q1 2023 · Jun 25, 2022 $323.22M
Sga Expense Q1 2023 · Sep 24, 2022 $17.85M
Sga Expense restated Q1 2023 · Sep 25, 2021 $32.65M
Net Income Q1 2023 · Sep 24, 2022 $4.16M
Net Income restated Q1 2023 · Sep 25, 2021 −$55.33M
Operating Income Q1 2023 · Sep 24, 2022 −$5.62M
Operating Income restated Q1 2023 · Sep 25, 2021 −$24.31M
Gross Profit Q1 2023 · Sep 24, 2022 $14.86M
Gross Profit restated Q1 2023 · Sep 25, 2021 $17.39M
Cost Of Revenue Q1 2023 · Sep 24, 2022 $15.19M
Cost Of Revenue restated Q1 2023 · Sep 25, 2021 $19.35M
Revenue Q1 2023 · Sep 24, 2022 $33.67M
Revenue Q1 2023 · Sep 25, 2021 $44.08M